Michelle Petri

Hydroxychloroquine: past, present, future
Lupus 1998 7: 65-67. [PDF] [References] [Request Permission]  

L Harper and COS Savage

Anti-heparin antibodies: part of the repertoire of anti-endothelial cell antibodies (AECA)
Lupus 1998 7: 68-72. [PDF] [References] [Request Permission]  

Patrick JW Venables

Undifferentiated connective tissue diseases: mixed or muddled?
Lupus 1998 7: 73-74. [PDF] [References] [Request Permission]  

Y Sherer and H Amital

The Eleventh Autoimmune Conference in honor of GRV Hughes and MD Kazatchkine, Tel-Aviv, Israel, 26 March, 1997
Lupus 1998 7: 75-79. [PDF] [Request Permission]  

The Canadian Hydroxychloroquine Study Group, E Tsakonas, L Joseph, J M Esdaile, D Choquette, J-L Senécal, A Cividino, D Danoff, C K Osterland, C Yeadon, and C D Smith

A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus
Lupus 1998 7: 80-85. [Abstract] [PDF] [References] [Request Permission]  

Y Renaudineau, R Revelen, A Bordron, D Mottier, P Youinou, and R Le Corre

Two populations of endothelial cell antibodies cross-react with heparin
Lupus 1998 7: 86-94. [Abstract] [PDF] [References] [Request Permission]  

M Mosca, A Tavoni, R Neri, W Bencivelli, and S Bombardieri

Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year
Lupus 1998 7: 95-100. [Abstract] [PDF] [References] [Request Permission]  

P R Fortin, M Abrahamowicz, C Neville, R du Berger, L Fraenkel, A E Clarke, and D Danoff

Impact of disease activity and cumulative damage on the health of lupus patients
Lupus 1998 7: 101-107. [Abstract] [PDF] [References] [Request Permission]  

N Watanabe, T Kubota, N Miyasaka, and Y Kanai

Enhancement of hydroxyl radical DNA cleavage by serum anti-dsDNA antibodies in SLE
Lupus 1998 7: 108-112. [Abstract] [PDF] [References] [Request Permission]  

A Perniok, F Wedekind, M Herrmann, C Specker, and M Schneider

High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus
Lupus 1998 7: 113-118. [Abstract] [PDF] [References] [Request Permission]  

A Zonana-Nacach, A Camargo-Coronel, P Yáñez, M de Lourdes Sánchez, F J Jáimenez-Balderas, J Aceves-Avila, P Martínez-Osuna, J Fuentes, F Medina, and A Fraga

Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration
Lupus 1998 7: 119-123. [Abstract] [PDF] [References] [Request Permission]  

E Hachulla, U Michon-Pasturel, D Leys, J-P Pruvo, V Queyrel, E Masy, J Arvieux, C Caron, F Brevet-Coupeé, P-Y Hatron, and B Devulder

Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies
Lupus 1998 7: 124-131. [Abstract] [PDF] [References] [Request Permission]  

A Otte, S M Weiner, S Hoegerle, R Wolf, F D Juengling, H H Peter, and E U Nitzsche

Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study
Lupus 1998 7: 132-134. [Abstract] [PDF] [References] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.